2m 2m 2m 2m 2m 2m 2m
Liquidia (LQDA)
NASDAQ
$70.94-$0.27 (-0.38%)
Price as of Jul 14, 2026 4:17 AM EDT- $6.9BMarket Cap
- 391.78%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Liquidia (LQDA)
$70.94-$0.27 (-0.38%)
LQDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $71.21 | ||
Change | -$6.72 (-8.62%) | ||
Open | $76.53 | ||
High | $77.42 | ||
Low | $69.71 | ||
Previous Close | $77.93 | ||
Volume | 2,171,508 | ||
30-Day Average Volume | 2,450,550 | ||
1-Week Change | -10.10% | ||
1-Month Change | -0.03% | ||
1-Year Change | 391.78% | ||
3-Year Change | 790.13% | ||
5-Year Change | 2,597.35% | ||
Fundamentals | |||
Shares Outstanding | 88.9M | ||
Total Assets | $401.5M | ||
Market Cap | $6.9B | ||
Enterprise Value | $6.7B | ||
Period: QTR TTM FY | |||
Revenue | $129.9M | ||
Net Income | $52.9M | ||
Free Cash Flow | $50.2M | ||
EBIT | $56.8M | ||
EBITDA | $57.3M | ||
Net Working Capital | $183.3M | ||
EPS | $0.52 | ||
Enterprise Value/EBITDA | 117 | ||
Enterprise Value/Revenue | 52 | ||
P/B | 64 | ||
P/E | 150 | ||
PEG | 1 | ||
Price/Free Cash Flow | 138 | ||
Price/Operating Cash Flow | 131 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue